Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Using historical data can significantly enhance your ability to choose index funds. Learn how to leverage this information for better investments.
26,191 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
The Trade Desk is signaling a broader pivot beyond its core DSP strengths. This article breaks down how trade desk re...
February delivered a sharp move for Iren Limited as the market wrestled with a bold pivot from neocloud mining to AI ...
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
A quiet revolution in AI compute centers around CPUs designed for AI workloads. This article explains why the era of ...
As AI reshapes markets, Palantir’s unique software moat could ignite a new chapter in growth. This guide compares Pal...
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Sanofi is accelerating its internal AI push with a home grown assistant and a centralized data lake. The strategy aim...
Arm Holdings faces macro headwinds as the Fed signals restraint. Investors are weighing a buy, hold, sell: holdings f...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
Ethereum isn't resting on its laurels. A bold plan for 2029 aims to streamline the network, cut costs, and attract bu...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...